NOVA LEAP HEALTH CORP (NLH.CA) Fundamental Analysis & Valuation
TSX-V:NLH • CA66980G1090
Current stock price
0.32 CAD
-0.01 (-1.54%)
Last:
This NLH.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. NLH.CA Profitability Analysis
1.1 Basic Checks
- NLH had negative earnings in the past year.
- In the past year NLH had a positive cash flow from operations.
- In multiple years NLH reported negative net income over the last 5 years.
- In the past 5 years NLH always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of -0.81%, NLH is in line with its industry, outperforming 41.67% of the companies in the same industry.
- NLH's Return On Equity of -1.00% is in line compared to the rest of the industry. NLH outperforms 41.67% of its industry peers.
- NLH's Return On Invested Capital of 4.26% is in line compared to the rest of the industry. NLH outperforms 50.00% of its industry peers.
- NLH had an Average Return On Invested Capital over the past 3 years of 3.17%. This is below the industry average of 6.73%.
- The last Return On Invested Capital (4.26%) for NLH is above the 3 year average (3.17%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.81% | ||
| ROE | -1% | ||
| ROIC | 4.26% |
ROA(3y)0.1%
ROA(5y)0.68%
ROE(3y)0.25%
ROE(5y)1.16%
ROIC(3y)3.17%
ROIC(5y)N/A
1.3 Margins
- With a Operating Margin value of 3.52%, NLH perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
- With a Gross Margin value of 39.67%, NLH perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
- In the last couple of years the Gross Margin of NLH has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.52% | ||
| PM (TTM) | N/A | ||
| GM | 39.67% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.9%
GM growth 5Y3.18%
2. NLH.CA Health Analysis
2.1 Basic Checks
- NLH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- NLH has about the same amout of shares outstanding than it did 1 year ago.
- The number of shares outstanding for NLH has been increased compared to 5 years ago.
- The debt/assets ratio for NLH is higher compared to a year ago.
2.2 Solvency
- NLH has an Altman-Z score of 4.15. This indicates that NLH is financially healthy and has little risk of bankruptcy at the moment.
- With an excellent Altman-Z score value of 4.15, NLH belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
- NLH has a debt to FCF ratio of 1.88. This is a very positive value and a sign of high solvency as it would only need 1.88 years to pay back of all of its debts.
- The Debt to FCF ratio of NLH (1.88) is better than 100.00% of its industry peers.
- A Debt/Equity ratio of 0.04 indicates that NLH is not too dependend on debt financing.
- NLH has a better Debt to Equity ratio (0.04) than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 1.88 | ||
| Altman-Z | 4.15 |
ROIC/WACC0.55
WACC7.81%
2.3 Liquidity
- A Current Ratio of 0.96 indicates that NLH may have some problems paying its short term obligations.
- NLH's Current ratio of 0.96 is in line compared to the rest of the industry. NLH outperforms 58.33% of its industry peers.
- NLH has a Quick Ratio of 0.96. This is a bad value and indicates that NLH is not financially healthy enough and could expect problems in meeting its short term obligations.
- NLH has a Quick ratio (0.96) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.96 |
3. NLH.CA Growth Analysis
3.1 Past
- NLH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -113.21%.
- Looking at the last year, NLH shows a very strong growth in Revenue. The Revenue has grown by 22.15%.
- The Revenue has been growing by 12.70% on average over the past years. This is quite good.
EPS 1Y (TTM)-113.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.83%
Revenue 1Y (TTM)22.15%
Revenue growth 3Y3.72%
Revenue growth 5Y12.7%
Sales Q2Q%22.81%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. NLH.CA Valuation Analysis
4.1 Price/Earnings Ratio
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- NLH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. NLH is cheaper than 75.00% of the companies in the same industry.
- The rest of the industry has a similar Price/Free Cash Flow ratio as NLH.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.94 | ||
| EV/EBITDA | 11.13 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. NLH.CA Dividend Analysis
5.1 Amount
- No dividends for NLH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NLH.CA Fundamentals: All Metrics, Ratios and Statistics
TSX-V:NLH (3/27/2026, 7:00:00 PM)
0.32
-0.01 (-1.54%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-05 2026-03-05
Earnings (Next)05-06 2026-05-06
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners18.98%
Ins Owner ChangeN/A
Market Cap27.94M
Revenue(TTM)31.47M
Net Income(TTM)-189.80K
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.64 | ||
| P/FCF | 12.94 | ||
| P/OCF | 12.94 | ||
| P/B | 1.06 | ||
| P/tB | 14.04 | ||
| EV/EBITDA | 11.13 |
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY7.73%
OCF(TTM)0.02
OCFY7.73%
SpS0.5
BVpS0.3
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.81% | ||
| ROE | -1% | ||
| ROCE | 5.6% | ||
| ROIC | 4.26% | ||
| ROICexc | 4.61% | ||
| ROICexgc | 128.53% | ||
| OM | 3.52% | ||
| PM (TTM) | N/A | ||
| GM | 39.67% | ||
| FCFM | 4.95% |
ROA(3y)0.1%
ROA(5y)0.68%
ROE(3y)0.25%
ROE(5y)1.16%
ROIC(3y)3.17%
ROIC(5y)N/A
ROICexc(3y)3.41%
ROICexc(5y)N/A
ROICexgc(3y)65.83%
ROICexgc(5y)N/A
ROCE(3y)4.17%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.9%
GM growth 5Y3.18%
F-Score5
Asset Turnover1.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 1.88 | ||
| Debt/EBITDA | 0.37 | ||
| Cap/Depr | 0% | ||
| Cap/Sales | 0% | ||
| Interest Coverage | 4.68 | ||
| Cash Conversion | 80.26% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | 4.15 |
F-Score5
WACC7.81%
ROIC/WACC0.55
Cap/Depr(3y)2.48%
Cap/Depr(5y)2.54%
Cap/Sales(3y)0.07%
Cap/Sales(5y)0.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-113.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.15%
Revenue growth 3Y3.72%
Revenue growth 5Y12.7%
Sales Q2Q%22.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y28.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y14.19%
FCF growth 3Y17.91%
FCF growth 5Y-12.33%
OCF growth 1Y12.13%
OCF growth 3Y15.1%
OCF growth 5Y-12.37%
NOVA LEAP HEALTH CORP / NLH.CA Fundamental Analysis FAQ
What is the ChartMill fundamental rating of NOVA LEAP HEALTH CORP (NLH.CA) stock?
ChartMill assigns a fundamental rating of 4 / 10 to NLH.CA.
What is the valuation status of NOVA LEAP HEALTH CORP (NLH.CA) stock?
ChartMill assigns a valuation rating of 2 / 10 to NOVA LEAP HEALTH CORP (NLH.CA). This can be considered as Overvalued.
How profitable is NOVA LEAP HEALTH CORP (NLH.CA) stock?
NOVA LEAP HEALTH CORP (NLH.CA) has a profitability rating of 5 / 10.